Double-blind trial of the treatment of episcleritis-scleritis with oxyphenbutazone or prednisolone (original) (raw)

463

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON B., MARGOLIS G. Scleromalacia; clinical and pathologic study of a case with consideration of differential diagnosis, relationship of collagen disease, and effect of ACTH and cortisone therapy. Am J Ophthalmol. 1952 Jul;35(7):917–931. [PubMed] [Google Scholar]
  2. BANNERJEE S. K., TAYLOR P. Hydroxyphenylbutazone in the treatment of nodular scleritis. Trans Ophthalmol Soc U K. 1961;81:651–652. [PubMed] [Google Scholar]
  3. BYWATERS E. G., HOLLOWAY V. P. MEASUREMENT OF SERUM URIC ACID IN GREAT BRITAIN IN 1963. Ann Rheum Dis. 1964 May;23:236–239. doi: 10.1136/ard.23.3.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. DUKE-ELDER S., DUTHIE O. M., FOSTER J., LAW F. W., LISTER A., MCKIE REID A., SCOTT G. I., ZORAB E. C., GOLDSMITH A. J. B. A series of cases treated locally by cortisone; a preliminary report to the Medical Council by the panel on the ophthalmological applications of cortisone and ACTH. Br J Ophthalmol. 1951 Nov;35(11):672–694. doi: 10.1136/bjo.35.11.672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. WERNER L. E. Hydroxy-phenylbutazone (Tanderil) in the treatment of ocular disease. A preliminary survey. Br J Ophthalmol. 1960 Dec;44:755–760. doi: 10.1136/bjo.44.12.755. [DOI] [PMC free article] [PubMed] [Google Scholar]